ENVALITH
株式会社カイノス logo

KAINOS Laboratories, INC.

4556Standard MarketPharmaceuticals

株式会社カイノス logo
KAINOS Laboratories, INC.4556

Governance

The Board of Directors consists of 7 members (including 4 outside directors, an outside ratio of approximately 57%), and the company is a Company with a Board of Corporate Auditors. The Board of Corporate Auditors is composed solely of 3 outside auditors, and the Board of Directors meets once a month. No Nomination Committee or Compensation Committee has been confirmed to be established.

Outside Director Ratio

57.1%

Nomination Committee

Not Established

Compensation Committee

Not Established

Risk Management

Sustainability-related risks are managed by the Performance Evaluation Meeting (held monthly), which is composed of the President and Representative Director and other full-time directors and executive officers, and important matters are reported to the Management Committee and the Board of Directors. The company identifies human resource acquisition and turnover risk as a key risk and works to mitigate it through measures such as the self-reporting system.

Shareholder Returns

To accept a tender offer by Flowers Co., Ltd., with delisting expected to follow. Dividend for FY2026 (ending March 2026) is set at ¥0 (no dividend). The dividend forecast for FY2027 (ending March 2026) is also undisclosed. Disposal of treasury shares (¥104,711 thousand) was carried out in connection with the tender offer.

Dividend Policy

For FY2026 (ending March 2026), no dividend will be paid (¥0 per share) due to the progress of procedures related to the tender offer. The dividend forecast for FY2027 (ending March 2026) is undisclosed because the Company's shares are expected to be delisted as a result of the tender offer by Flowers Co., Ltd. and the subsequent series of procedures. Note that in FY2025 (ended March 2025), a dividend of ¥35 per share was paid (ordinary dividend of ¥32 plus a 50th anniversary commemorative dividend of ¥3), totaling ¥155 million (payout ratio of 23.0%).

Dividend

None

Share Buyback

None

Shareholder Benefits

None

ESG

Four materialities have been identified: "Contribution to Healthcare," "A Workplace Where People Can Work Comfortably," "Harmony with the Environment," and "Governance." As an indicator of human capital diversity, the company has set a target for the male-female ratio of average years of continuous service (target: 80% or higher by the end of March 2026; actual: 75.9%), and is promoting the development of childcare/family care leave and work-from-home systems. No quantitative disclosure regarding climate change has been confirmed.

Last updated: June 20, 2025